7
MAY
Reports
Q1, 2024 earnings report expected
SUPN
Supernus Pharmaceuticals Inc
0
0
(0%)
EPS
$0.376667
Estimated Sales
$145.83M
Market Cap
$1.7B
SUPN
0.56 (1.26%)
45.01
45.03
@MarketUpdates
United Kingdom
7
MAY
Reports
Q1, 2024 earnings report expected
SUPN
Supernus Pharmaceuticals Inc
0
0
(0%)
EPS
$0.376667
Estimated Sales
$145.83M
Market Cap
$1.7B
1 Mentioned
SUPN
Supernus Pharmaceuticals Inc
.
